These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12867574)

  • 1. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
    Masilamani M; von Kempis J; Illges H
    Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
    Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
    Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD21 in sera and synovial fluid of arthritic patients.
    Grottenthaler T; von Kempis J; Goldacker S; Illges H
    Rheumatol Int; 2006 Jan; 26(3):240-3. PubMed ID: 15770483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis.
    Masilamani M; Nowack R; Witte T; Schlesier M; Warnatz K; Glocker MO; Peter HH; Illges H
    Scand J Immunol; 2004 Dec; 60(6):625-30. PubMed ID: 15584974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.
    Larcher C; Kempkes B; Kremmer E; Prodinger WM; Pawlita M; Bornkamm GW; Dierich MP
    Eur J Immunol; 1995 Jun; 25(6):1713-9. PubMed ID: 7614999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation.
    Masilamani M; Apell HJ; Illges H
    J Immunol Methods; 2002 Dec; 270(1):11-8. PubMed ID: 12379334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
    Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
    Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.
    Singh A; Vastert SJ; Prakken BJ; Illges H
    Rheumatol Int; 2012 Jun; 32(6):1581-7. PubMed ID: 21328056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.
    Masilamani M; Rajasekaran N; Singh A; Low HZ; Albus K; Anders S; Behne F; Eiermann P; König K; Mindnich C; Ribarska T; Illges H
    Rheumatol Int; 2008 Sep; 28(11):1137-41. PubMed ID: 18500464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of soluble CD21 in patients with systemic sclerosis.
    Tomita M; Kadono T; Yazawa N; Kawashima T; Tamaki Z; Ashida R; Ohmatsu H; Asano Y; Sugaya M; Kubo M; Ihn H; Tamaki K; Sato S
    Rheumatol Int; 2012 Feb; 32(2):317-21. PubMed ID: 21052675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of Epstein-Barr virus receptor on lymphoblastoid cell lines from subsets of patients with rheumatoid arthritis.
    Kahan A; Charriaut-Marlangue C; Kahan A; Barel M; Menkes CJ; Amor B; Frade R
    J Rheumatol; 1986 Dec; 13(6):1024-7. PubMed ID: 3494120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the Epstein-Barr virus receptor CD21 in multiple sclerosis.
    Toepfner N; Cepok S; Grummel V; Hemmer B
    J Neuroimmunol; 2012 Jan; 242(1-2):47-51. PubMed ID: 22137275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of CD21 in peripheral blood B lymphocytes of neonates].
    Zhang R; Wang QJ; Xu JM; Jiang L; Shou WZ; Yin Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):546-8. PubMed ID: 18082036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.
    Kremlitzka M; Polgár A; Fülöp L; Kiss E; Poór G; Erdei A
    Int Immunol; 2013 Jan; 25(1):25-33. PubMed ID: 22962438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-lymphocyte subpopulations in rheumatoid arthritis.
    Pfreundschuh M; Gause A; Dörken B; Gram N; Rehn C; Beck J
    Z Rheumatol; 1980; 39(9-10):348-55. PubMed ID: 6969958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23.
    Frémeaux-Bacchi V; Aubry JP; Bonnefoy JY; Kazatchkine MD; Kolb JP; Fischer EM
    Eur J Immunol; 1998 Dec; 28(12):4268-74. PubMed ID: 9862364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis.
    Masuda M; Morimoto T; De Haas M; Nishimura N; Nakamoto K; Okuda K; Komiyama Y; Ogawa R; Takahashi H
    J Rheumatol; 2003 Sep; 30(9):1911-7. PubMed ID: 12966590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.
    Tosato G; Steinberg AD; Yarchoan R; Heilman CA; Pike SE; De Seau V; Blaese RM
    J Clin Invest; 1984 Jun; 73(6):1789-95. PubMed ID: 6327772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.